162 related articles for article (PubMed ID: 9210690)
1. Prospective randomized comparison of cefodizime versus cefuroxime for perioperative prophylaxis in patients undergoing coronary artery bypass grafting.
Wenisch C; Bartunek A; Zedtwitz-Liebenstein K; Hiesmayr M; Parschalk B; Pernerstorfer T; Graninger W
Antimicrob Agents Chemother; 1997 Jul; 41(7):1584-8. PubMed ID: 9210690
[TBL] [Abstract][Full Text] [Related]
2. Effect of cefodizime and ceftriaxone on phagocytic function in patients with severe infections.
Wenisch C; Parschalk B; Hasenhündl M; Wiesinger E; Graninger W
Antimicrob Agents Chemother; 1995 Mar; 39(3):672-6. PubMed ID: 7793871
[TBL] [Abstract][Full Text] [Related]
3. Effect of preoperative prophylaxis with filgrastim in cancer neck dissection.
Wenisch C; Werkgartner T; Sailer H; Patruta S; Krause R; Daxboeck F; Parschalk B
Eur J Clin Invest; 2000 May; 30(5):460-6. PubMed ID: 10809907
[TBL] [Abstract][Full Text] [Related]
4. Cefodizime (HR 221) potentiation of human neutrophil oxygen-independent bactericidal activity.
Labro MT; Amit N; Babin-Chevaye C; Hakim J
J Antimicrob Chemother; 1987 Mar; 19(3):331-41. PubMed ID: 3032885
[TBL] [Abstract][Full Text] [Related]
5. Comparison of vancomycin and cefuroxime for infection prophylaxis in coronary artery bypass surgery.
Vuorisalo S; Pokela R; Syrjälä H
Infect Control Hosp Epidemiol; 1998 Apr; 19(4):234-9. PubMed ID: 9605271
[TBL] [Abstract][Full Text] [Related]
6. Cefodizime: effects of sub-inhibitory concentrations on adhesiveness and bacterial morphology of Staphylococcus aureus and Escherichia coli: comparison with cefotaxime and ceftriaxone.
Braga PC; Dal Sasso M; Maci S
J Antimicrob Chemother; 1997 Jan; 39(1):79-84. PubMed ID: 9044031
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation and immunomodulatory study of cefodizime].
Li G; Zhang Y; Ji M
Zhonghua Nei Ke Za Zhi; 1997 Nov; 36(11):759-63. PubMed ID: 10451950
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of cefodizime, cefuroxime, ceftriaxone against respiratory pathogens.
Paniara O; Platsouka E; Dimopoulou H; Constantoulaki S
J Chemother; 1994 Feb; 6(1):35-8. PubMed ID: 8071676
[TBL] [Abstract][Full Text] [Related]
9. Electrophoretic mobility of cefodizime-treated Staphylococcus aureus and chemiluminescence of human polymorphonuclear leucocytes.
Muratsugu M; Tomonaga M; Miyake Y; Terayama K; Ishida N
J Antimicrob Chemother; 1991 Dec; 28(6):887-96. PubMed ID: 1816185
[TBL] [Abstract][Full Text] [Related]
10. Effect of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by flow cytometry.
Wenisch C; Parschalk B; Zedtwitz-Liebenstein K; Weihs A; el Menyawi I; Graninger W
Antimicrob Agents Chemother; 1996 Sep; 40(9):2039-42. PubMed ID: 8878577
[TBL] [Abstract][Full Text] [Related]
11. Cefodizime, an aminothiazolyl cephalosporin. III. Therapeutic activity against experimentally induced pneumonia in mice.
Klesel N; Limbert M; Seibert G; Winkler I; Schrinner E
J Antibiot (Tokyo); 1984 Dec; 37(12):1712-8. PubMed ID: 6098572
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic prophylaxis in open-heart surgery patients: comparison of cefamandole and cefuroxime.
Peterson CD; Lake KD; Arom KV; Love KR
Drug Intell Clin Pharm; 1987 Sep; 21(9):728-32. PubMed ID: 3498617
[TBL] [Abstract][Full Text] [Related]
13. Mild intraoperative hypothermia reduces production of reactive oxygen intermediates by polymorphonuclear leukocytes.
Wenisch C; Narzt E; Sessler DI; Parschalk B; Lenhardt R; Kurz A; Graninger W
Anesth Analg; 1996 Apr; 82(4):810-6. PubMed ID: 8615502
[TBL] [Abstract][Full Text] [Related]
14. Effects of cefotaxime and cefodizime on human granulocyte functions in vitro.
Labro MT; Babin-Chevaye C; Hakim J
J Antimicrob Chemother; 1986 Aug; 18(2):233-7. PubMed ID: 3019985
[TBL] [Abstract][Full Text] [Related]
15. Decrease in surface charge density of Klebsiella pneumoniae treated with cefodizime and enhancement of the phagocytic function of human polymorphonuclear leucocytes stimulated by the drug-treated bacteria.
Muratsugu M; Miyake Y; Ishida N; Hyodo A; Terayama K
Biol Pharm Bull; 1995 Sep; 18(9):1259-63. PubMed ID: 8845818
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of ceftriaxone and cefuroxime for perioperative prophylaxis in orthopedic surgery.
Meyer JM
Am J Surg; 1984 Oct; 148(4A):27-9. PubMed ID: 6091477
[TBL] [Abstract][Full Text] [Related]
17. Influence of sub-minimum inhibitory concentrations of cefodizime on the phagocytosis, intracellular killing and oxidative bursts of human polymorphonuclear leukocytes.
Braga PC; Dal Sasso M; Mancini L; Sala MT
Chemotherapy; 1999; 45(3):166-74. PubMed ID: 10224338
[TBL] [Abstract][Full Text] [Related]
18. In-vitro effects of cefodizime on leucocyte functions and colony formation from granulocyte-monocyte progenitors.
Shin WS; Min CK; Kim YR; Yoo JH; Kang MW
J Antimicrob Chemother; 1996 Jan; 37(1):93-103. PubMed ID: 8647779
[TBL] [Abstract][Full Text] [Related]
19. Is single-dose antibiotic prophylaxis sufficient for coronary artery bypass surgery? An analysis of peri- and postoperative serum cefuroxime and vancomycin levels.
Vuorisalo S; Pokela R; Syrjälä H
J Hosp Infect; 1997 Nov; 37(3):237-47. PubMed ID: 9421775
[TBL] [Abstract][Full Text] [Related]
20. Perioperative antimicrobial prophylaxis in cardiovascular surgery. A prospective randomized trial comparing two day cefuroxime prophylaxis with four day cefazolin prophylaxis.
Geroulanos S; Oxelbark S; Turina M
J Cardiovasc Surg (Torino); 1986; 27(3):300-6. PubMed ID: 3514630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
